INDV

Dopo l'orario di chiusura: 33.30 0.07 +0.21%

Indivior Pharmaceuticals Inc (INDV)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Indivior Pharmaceuticals Inc

Healthcare (1108)

804-379-1090

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

Prossima data di guadagno

Ultimi documenti SEC

INDV's Discussions on Twitter

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INDV Indivior Pharmaceuticals Inc	33.23	4.04B	1.24B	209.00M	-94.86M	1.6605
TAK Takeda Pharmaceutical Co Adr	16.63	52.60B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	116.87	48.81B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.58	42.40B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.64	36.34B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	567.16	25.11B	3.18B	1.33B	1.04B	27.90

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-06	Iniziato	H.C. Wainwright	Buy
2025-07-22	Ripresa	Jefferies	Buy
2025-01-28	Iniziato	Rodman & Renshaw	Buy
2024-07-23	Iniziato	Piper Sandler	Overweight
2024-04-03	Iniziato	Craig Hallum	Buy
2023-07-13	Iniziato	Northland Capital	Outperform

Mostra tutto

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Indivior Pharmaceuticals Inc Azioni (INDV) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Kingsley Stuart A	Director	Mar 06 '26	Buy	31.86	940	29,953	5,582
Ryan Barbara	Director	Mar 09 '26	Buy	32.56	31	1,009	5,716
Ryan Barbara	Director	Jan 05 '26	Buy	35.39	775	27,429	1,963
Humphreys Keith	Director	Jan 05 '26	Buy	35.39	775	27,429	5,802
NINIVAGGI DANIEL A	Director	Jan 05 '26	Buy	35.39	775	27,429	16,923
Stejbach Mark	Director	Jan 05 '26	Buy	35.39	775	27,429	16,847
Wheadon David E.	Director	Jan 05 '26	Buy	35.39	1,771	62,680	14,395

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

Indivior (INDV) Showcases Research on Buprenorphine at Addiction Medicine Conference - GuruFocus

Indivior Pharmaceuticals Collaborates with Virginia Tech on Research Highlighting Remission and Treatment Outcomes in Opioid Use Disorder at ASAM Conference - Quiver Quantitative

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder - ChartMill

Indivior plans $400M convertible senior notes offering - MSN

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV) - MSN

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN

A Look at Indivior Pharmaceuticals Inc (INDV) After 3.6% Gain -- GF Value $21.89 vs Price $33.39 - GuruFocus

Does Indivior (INDV) Survey Support For Long-Acting Buprenorphine Strengthen Its Criminal Justice Strategy? - Sahm

Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates - Eastern Progress

Indivior Pharmaceuticals Inc (INDV) Shares Fall 3.1% -- What GF Score of 69 Tells Investors - GuruFocus

Indivior Pharmaceuticals (INDV) Valuation Check After Recent Share Price Volatility - Yahoo Finance

Indivior PLC Survey Highlights Correctional Leaders' Support for Long-Acting Injectable Buprenorphine to Mitigate MOUD Diversion - Quiver Quantitative

Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse - GlobeNewswire

INDV Insider Filing: Barry Patrick Restricted Stock Units April 2026 - Meyka

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug - The Globe and Mail

Assessing Indivior (INDV) Valuation After New SUBLOCADE Study In Correctional Healthcare - Sahm

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists - Investor's Business Daily

A Look at Indivior Pharmaceuticals Inc (INDV) After 3.5% Gain -- GF Value $21.93 vs Price $31.60 - GuruFocus

Has The Strong Three-Year Run Left Indivior Pharmaceuticals (INDV) Priced Too Richly Today? - Yahoo Finance

How does Indivior Pharmaceuticals (INDV) Stock perform in rallies | INDV Q4 Earnings: Beats Estimates by $0.13Pre Announcement - Cổng thông tin điện tử Tỉnh Sơn La

How much upside is left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street analysts think 45.99% - MSN

Indivior Lends Voice to Help Raise Awareness of Substance Use Di - GuruFocus

If You Invested $1,000 in Indivior Pharmaceuticals Inc. (INDV) - Stock Titan

Indivior Pharmaceuticals Inc (INDV) Stock Down 5.5% but Still Ov - GuruFocus

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results - TradingView — Track All Markets

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200 - TradingView

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99% - Yahoo Finance

Indivior to Report Q1 2026 Earnings, Host Webcast - National Today

Indivior to Report First Quarter 2026 Financial Results - National Today

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th - The Manila Times

Indivior investors get Q1 results at 7 a.m., webcast at 8 a.m. EDT - Stock Titan

Is Indivior Pharmaceuticals (INDV) Stock Breaking Out | Price at $30.47, Up 0.16%Street Ratings - UBND thành phố Hải Phòng

Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics - Bitget

IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints - TradingView

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - zacks.com

Is Indivior Pharmaceuticals (INDV) Stock Gaining Momentum | Price at $30.63, Up 0.53%Stock News - Xã Châu Thành

INDV Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

INDV | Indivior Pharmaceuticals, Inc. Common Executive Compensation - Quiver Quantitative

INDV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

INDV Technical Analysis & Stock Price Forecast - Intellectia AI

Assessing Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After New SUBLOCADE Cost Savings Evidence In Corrections Settings - Sahm

Indivior Pharmaceuticals Inc. R (E7P.F) Insider Ownership & Holdings - Yahoo! Finance Canada

JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV - MarketBeat

Did Potential Jail Staffing Efficiencies From SUBLOCADE® Just Shift Indivior Pharmaceuticals' (INDV) Investment Narrative? - Sahm

Indivior Pharmaceuticals, Inc. (INDV) stock price, news, quote and history - Yahoo Finance UK

Small Cap Index Trust's Indivior Pharmaceuticals Inc(INDV) Holding History - GuruFocus

Indivior Pharmaceuticals Inc. R (E7P.F) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada

Indivior Pharmaceuticals, Inc. (INDV) Stock forecasts - Yahoo Finance UK

Is Indivior Pharmaceuticals (INDV) Stock Good for Portfolio | Price at $30.47, Down 0.59%Verified Analyst Reports - Xã Châu Thành

What Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For Shareholders - Yahoo Finance

Indivior Pharmaceuticals, Inc. (INDV) Stock Forecasts - finance.yahoo.com

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Indivior Pharmaceuticals Inc Azioni (INDV) insider trading

Simile a INDV